|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/165 | (2006.01) |
| A61K 31/19 | (2006.01) | ||
| A61P 25/02 | (2006.01) |
| (11) | Number of the document | 3402474 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17701646.6 |
| Date of filing the European patent application | 2017-01-13 | |
| (97) | Date of publication of the European application | 2018-11-21 |
| (45) | Date of publication and mention of the grant of the patent | 2021-07-21 |
| (46) | Date of publication of the claims translation | 2021-11-25 |
| (86) | Number | PCT/EP2017/050637 |
| Date | 2017-01-13 |
| (87) | Number | WO 2017/121838 |
| Date | 2017-07-20 |
| (30) | Number | Date | Country code |
| 16151618 | 2016-01-15 | EP | |
| 16190871 | 2016-09-27 | EP |
| (72) |
BRANDOLINI, Laura , IT
RUFFINI, Pier Adelchi , IT
ALLEGRETTI, Marcello , IT
|
| (73) |
Dompé farmaceutici S.p.A. ,
Via S. Martino Della Battaglia 12, 20122 Milano,
IT
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | IL-8 inhibitoriai, skirti panaudoti chemoterapijos sukeltos periferinės neuropatijos gydymui |
| IL-8 INHIBITORS FOR USE IN THE TREATMENT OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY |
| Payment date | Validity (years) | Amount | |
| 2025-12-18 | 10 | 231.00 EUR |
| 2027-01-13 |